{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:11:49Z","timestamp":1793391109557,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ijcard.2019.01.020","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T21:45:06Z","timestamp":1550267106000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Danon disease: Gender differences in presentation and outcomes"],"prefix":"10.1016","volume":"286","author":[{"given":"Michela","family":"Brambatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Caspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Maolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Koshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.G.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-0188","authenticated-orcid":false,"given":"Eric D.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.01.020_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/auto.1.1.1270","article-title":"Maturation of autophagic vacuoles in mammalian cells","volume":"1","author":"Eskelinen","year":"2005","journal-title":"Autophagy"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0010","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/hrt.2003.029504","article-title":"Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey","volume":"90","author":"Charron","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0020","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.105.546481","article-title":"Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children","volume":"112","author":"Yang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/GIM.0b013e31820ad795","article-title":"Natural history of Danon disease","volume":"13","author":"Boucek","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0030","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0035","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjcard.2011.09.024","article-title":"Sudden death associated with danon disease in women","volume":"109","author":"Miani","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijcard.2017.06.031","article-title":"Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy)","volume":"245","author":"Samad","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.carpath.2016.07.005","article-title":"A novel LAMP2 mutation associated with severe cardiac hypertrophy and microvascular remodeling in a female with Danon disease: a case report and literature review","volume":"25","author":"Bottillo","year":"2016","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0050","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCHEARTFAILURE.114.001105","article-title":"Danon disease: clinical features, evaluation, and management","volume":"7","author":"D'souza","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0055","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/35022595","article-title":"Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice","volume":"406","author":"Tanaka","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yjmcc.2017.05.007","article-title":"Impaired mitophagy facilitates mitochondrial damage in Danon disease","volume":"108","author":"Hashem","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0065","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/stem.2015","article-title":"Brief report: oxidative stress mediates cardiomyocyte apoptosis in a human model of Danon disease and heart failure","volume":"33","author":"Hashem","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113507","article-title":"A nationwide survey on Danon disease in Japan","volume":"19","author":"Sugie","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0080","article-title":"Clinical findings and prognosis of Danon disease. An analysis of the Spanish Multicenter Danon Registry","author":"Lopez-Sainz","year":"2018","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0085","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.CIR.0000075270.13497.2B","article-title":"Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy","volume":"107","author":"Arad","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0090","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0095","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy","volume":"58","author":"Gersh","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.01.020_bb0100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ehjci\/jex323","article-title":"Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: the importance of clinical context","volume":"19","author":"Quarta","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0105","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/ehjci\/jes099","article-title":"Incremental value of three-dimensional strain imaging in Danon disease","volume":"13","author":"Miani","year":"2012","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0110","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/heartjnl-2015-308453","article-title":"Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy","volume":"102","author":"Magri","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2019.01.020_bb0115","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/mus.21614","article-title":"A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease","volume":"41","author":"Kim","year":"2010","journal-title":"Muscle Nerve"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318370840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318370840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:41:32Z","timestamp":1759092092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318370840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":23,"alternative-id":["S0167527318370840"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.01.020","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danon disease: Gender differences in presentation and outcomes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}